130 related articles for article (PubMed ID: 9726012)
21. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.
Aplan PD; Lombardi DP; Ginsberg AM; Cossman J; Bertness VL; Kirsch IR
Science; 1990 Dec; 250(4986):1426-9. PubMed ID: 2255914
[TBL] [Abstract][Full Text] [Related]
22. Nucleotide sequence analysis of human hypoxanthine phosphoribosyltransferase (HPRT) gene deletions.
Monnat RJ; Hackmann AF; Chiaverotti TA
Genomics; 1992 Jul; 13(3):777-87. PubMed ID: 1639404
[TBL] [Abstract][Full Text] [Related]
23. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
Oettinger MA; Schatz DG; Gorka C; Baltimore D
Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
[TBL] [Abstract][Full Text] [Related]
24. Disruption of the multiple tumor suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias.
Cayuela JM; Gardie B; Sigaux F
Blood; 1997 Nov; 90(9):3720-6. PubMed ID: 9345058
[TBL] [Abstract][Full Text] [Related]
25. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
[TBL] [Abstract][Full Text] [Related]
26. Coding joint formation of endogenous T cell receptor genes in lymphoid cells from scid mice: unusual P-nucleotide additions in VJ-coding joints.
Schuler W; Ruetsch NR; Amsler M; Bosma MJ
Eur J Immunol; 1991 Mar; 21(3):589-96. PubMed ID: 1849083
[TBL] [Abstract][Full Text] [Related]
27. Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
Carcinogenesis; 1994 Jul; 15(7):1463-6. PubMed ID: 8033326
[TBL] [Abstract][Full Text] [Related]
28. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke.
Finette BA; O'Neill JP; Vacek PM; Albertini RJ
Nat Med; 1998 Oct; 4(10):1144-51. PubMed ID: 9771747
[TBL] [Abstract][Full Text] [Related]
29. RAG-1 and RAG-2 gene expression and V(D)J recombinase activity are enhanced by protein phosphatase 1 and 2A inhibition in lymphocyte cell lines.
Casillas AM; Thompson AD; Cheshier S; Hernandez S; Aguilera RJ
Mol Immunol; 1995 Feb; 32(3):167-75. PubMed ID: 7898493
[TBL] [Abstract][Full Text] [Related]
30. The V(D)J recombination activating gene, RAG-1.
Schatz DG; Oettinger MA; Baltimore D
Cell; 1989 Dec; 59(6):1035-48. PubMed ID: 2598259
[TBL] [Abstract][Full Text] [Related]
31. Impairment of V(D)J recombination in double-strand break repair mutants.
Taccioli GE; Rathbun G; Oltz E; Stamato T; Jeggo PA; Alt FW
Science; 1993 Apr; 260(5105):207-10. PubMed ID: 8469973
[TBL] [Abstract][Full Text] [Related]
32. Sequence analysis of deletion mutations at the HPRT locus of human T-lymphocytes: association of a palindromic structure with a breakpoint cluster in exon 2.
Osterholm AM; Bastlová T; Meijer A; Podlutsky A; Zanesi N; Hou SM
Mutagenesis; 1996 Sep; 11(5):511-7. PubMed ID: 8921514
[TBL] [Abstract][Full Text] [Related]
33. Deletion and insertion in vivo somatic mutations in the hypoxanthine phosphoribosyltransferase (hprt) gene of human T-lymphocytes.
Burkhart-Schultz KJ; Jones IM
Environ Mol Mutagen; 1997; 30(4):371-84. PubMed ID: 9435878
[TBL] [Abstract][Full Text] [Related]
34. Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.
Williams CJ; Grandal I; Vesprini DJ; Wojtyra U; Danska JS; Guidos CJ
Mol Cell Biol; 2001 Jan; 21(2):400-13. PubMed ID: 11134329
[TBL] [Abstract][Full Text] [Related]
35. Use of inverse PCR to amplify and sequence breakpoints of HPRT deletion and translocation mutations.
Williams M; Rainville IR; Nicklas JA
Environ Mol Mutagen; 2002; 39(1):22-32. PubMed ID: 11813293
[TBL] [Abstract][Full Text] [Related]
36. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination.
Laquerbe A; Moustacchi E; Fuscoe JC; Papadopoulo D
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):831-5. PubMed ID: 7846061
[TBL] [Abstract][Full Text] [Related]
37. Molecular markers of ionizing radiation-induced gene mutations in mammalian cells.
Hsie AW; Porter RC; Xu Z; Yu Y; Sun J; Meltz ML; Schwartz JL
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):675-8. PubMed ID: 8781403
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of hypoxanthine phosphoribosyltransferase gene deletions induced by alpha- and X-radiation in human lymphoblastoid cells.
Bao CY; Ma AH; Evans HH; Horng MF; Mencl J; Hui TE; Sedwick WD
Mutat Res; 1995 Jan; 326(1):1-15. PubMed ID: 7528877
[TBL] [Abstract][Full Text] [Related]
39. V(D)J recombination in ataxia telangiectasia, Bloom's syndrome, and a DNA ligase I-associated immunodeficiency disorder.
Hsieh CL; Arlett CF; Lieber MR
J Biol Chem; 1993 Sep; 268(27):20105-9. PubMed ID: 8397200
[TBL] [Abstract][Full Text] [Related]
40. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
